Xconomy Boston

Hepregen Inc. Garners $3,000,000 Series A Round

  • Feed Type
  • Date
    8/29/2008
  • Company Name
    Hepregen Inc.
  • Mailing Address
    24 Calumet Road Winchester, ME 01890-3535
  • Company Description
    The company is focused on developing products that reduce the liver toxicity of existing pharmaceuticals
  • Website
    Undisclosed
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $3,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Battelle Ventures
  • Venture Investor
    Innovation Valley Partners

Add Your Thoughts

You will have 10 minutes to edit your post after you press publish.

Comments may be edited for clarity and length, rejected, or deleted.
By clicking "Publish," you are agreeing to these Terms and Conditions.

    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.